FDA issued a Warning Letter to Zhejiang Hisun Pharmaceutical Co., Ltd. on 12/31/2015 for a previous inspection.
483 Zhejiang Hisun Pharmaceutical Aug 2017

483 Zhejiang Hisun Pharmaceutical Aug 2017

Peter Baker FDA, Parul Patel FDA$119.00 - Available Now

FDA investigators audited the Zhejiang Hisun Pharmaceutical - Taizhou, China facility and issued inspectional observations (via FDA 483) on 11 Aug 2017.

Product details

  • Category: Animal Drugs & Feeds / Human Drugs
  • Inspection end: 11 Aug 2017
  • Location: Taizhou, China
  • FEI: 3007719313
Add To Cart